NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00605735,PoC in Rheumatoid Arthritis With Methotrexate,https://clinicaltrials.gov/study/NCT00605735,,COMPLETED,The purpose of this study is to find out if 300 mg of BMS-582949 given once daily will be more effective than placebo after 12 weeks of treatment in subjects with rheumatoid arthritis who are also taking methotrexate,NO,"Rheumatoid Arthritis, NOS",DRUG: BMS-582949|DRUG: Placebo,"The primary endpoint is the proportion of subjects achieving an ACR 20 at Week 12, at Week 12","Proportion of subjects achieving an ACR 20, at each scheduled visit|Proportion of subjects schieving and ACR 50, at each scheduled visit|Proportion of subjects schieving and ACR 70, at each scheduled visit|Percent change from baseline to each scheduled visit in DAS28 score, at each scheduled visit|Percent change from baseline to each scheduled visit in ACR scores, at each scheduled visit|Proportion of subjects schieving a 20% change in assessment of pain, disease activity and fatigue, at each scheduled visit|Percent change from baseline to each scheduled visit in HAQ score, at each scheduled visit",,Bristol-Myers Squibb,,ALL,"ADULT, OLDER_ADULT",PHASE2,121,INDUSTRY,INTERVENTIONAL,"Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT",IM119-015,2008-03,2009-08,2009-09,2008-01-31,,2015-10-12,"Desert Medical Advances, Palm Desert, California, 92260, United States|Orrin M. Troum,M D, Santa Monica, California, 90404, United States|G. Timothy Kelly, Md, Las Vegas, Nevada, 81928, United States|Health Research Of Oklahoma, Oklahoma City, Oklahoma, 73103, United States|The Arthritis Group, Philadelphia, Pennsylvania, 19152, United States|Arthritis Clinic, Jackson, Tennessee, 38305, United States|Walter F Chase Md, Austin, Texas, 78705, United States|Tacoma Center For Arthritis Research Ps, Tacoma, Washington, 98405, United States|Local Institution, Capital Federal, Buenos Aires, 1431, Argentina|Local Institution, Ciudad Autonoma De Buenos Aire, Buenos Aires, C1034ACO, Argentina|Local Institution, Buenos Aires, 1426, Argentina|Local Institution, Ceske Budejovice, 370 01, Czech Republic|Local Institution, Hradec Kralove, 500 05, Czech Republic|Local Institution, Prague 2, 128 50, Czech Republic|Local Institution, Bordeaux Cedex, 33076, France|Local Institution, Chambray Les Tours, 37170, France|Local Institution, Paris Cedex 14, 75679, France|Local Institution, Cheonan, Choong Chung Nam-Do, 330-721, Korea, Republic of|Local Institution, Mexico, Distrito Federal, 14080, Mexico|Local Institution, Guadalajara, Jalisco, 44200, Mexico|Local Institution, Guadalajara, Jalisco, 44500, Mexico|Local Institution, Culiacan, Sinaloa, 8000, Mexico|Local Institution, Nuevo Leon, 64020, Mexico|Local Institution, Madrid, 28046, Spain|Local Institution, Santiago De C., 15706, Spain|Local Institution, Vizcaya, 48903, Spain|Local Institution, Taichung, B, Taiwan|Local Institution, Taoyuan, 333, Taiwan",
